Extreme Movers: Perplexity's picks for 2026-10-23
Perplexity picked LKQ, MRNA, CCI, AMT, SPOT for a 1-day horizon. Average directional return: -1.37%. Directions called correctly: 20%.
| Experiment | Extreme Movers |
|---|---|
| Model | Perplexity |
| Prompt version | extreme-movers-v11 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-10-23 |
| Measured to | 2026-10-26 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | -1.37% |
| Directions called correctly | 20% |
| Benchmark return | +0.67% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | LKQ | up | -3.33% | -3.33% | 55% | -4.01% | No |
| 2 | MRNA | up | +0.94% | +0.94% | 50% | +0.27% | Yes |
| 3 | CCI | up | -1.13% | -1.13% | 60% | -1.81% | No |
| 4 | AMT | up | -2.08% | -2.08% | 55% | -2.75% | No |
| 5 | SPOT | up | -1.25% | -1.25% | 60% | -1.92% | No |
The model's market view
The source session was Thursday, October 22, 2026, when a broad AI/technology selloff drove the Nasdaq down 2.60% and the S&P 500 down 1.21%, while the Dow closed marginally higher. The five selections pair two oversold losers with potential stabilization bounces against three earnings- or news-driven gainers where momentum may persist. The market remains catalyst-driven and volatile, so single-day reversal and continuation calls carry elevated uncertainty.
Why each pick
LKQ
LKQ was the largest S&P 500 loser in the October 22 source session, falling 20.84%, reportedly after results/guidance-related selling; the move was substantive rather than merely speculative. With the stock near its 52-week low and already deeply de-rated, I take a reversal-up stance for the next regular session, though the catalyst was fundamentally negative and continued downside is a material risk. Reference price is the latest Blue Ocean overnight quote of 21.42 USD on October 23; market cap is the Yahoo intraday figure of 5.409 billion USD. The 20-day average dollar volume is derived from Yahoo's reported 20-day average share volume of 3,368,733 multiplied by the latest price, approximately 72.0 million USD; I could not find a directly published dollar-volume figure.
MRNA
Moderna fell 17.57% in the October 22 source session after leaked Phase 3 melanoma-vaccine data reportedly met high expectations but trailed the most bullish projections; this was a substantive, binary clinical-data catalyst. The sell-off was extreme and the detailed data presentation was scheduled for October 24, creating potential for a stabilization or short-covering bounce, but the fundamental read-through was negative and further downside is equally plausible. Reference price is the latest Blue Ocean overnight quote of 203.69 USD on October 23; market cap is Yahoo's intraday figure of 80.897 billion USD. The 20-day average dollar volume is derived from Yahoo's average share volume of 19,703,756 times the latest price, approximately 4.013 billion USD; no directly published dollar-volume figure was found.
CCI
Crown Castle gained 14.02% in the October 22 source session after Bloomberg reported talks with SpaceX about tower leases for a potential 80,000-site U.S. wireless network; the report is substantive news but its commercial terms and probability remain uncertain, making part of the move speculative. The stock also reported a Q3 AFFO beat and raised full-year 2026 guidance, supporting continuation. I expect follow-through buying, though the story-driven premium can fade quickly if SpaceX talks are denied or delayed. Reference price is the latest Blue Ocean overnight quote of 84.10 USD on October 23; market cap is Yahoo's intraday figure of 34.449 billion USD. The 20-day average dollar volume is derived from Yahoo's average share volume of 4,016,395 times the latest price, approximately 337.8 million USD; no directly published dollar-volume figure was found.
AMT
American Tower rose 7.88% in the October 22 source session alongside Crown Castle on the reported SpaceX tower-leasing discussions; the catalyst is substantive sector news but still unconfirmed in commercial detail. As the larger, more liquid tower REIT, AMT may see continued rotational demand, but its smaller percentage move suggests less extreme positioning than CCI. I take continuation-up, with the main risk that the SpaceX narrative proves speculative and tower REITs give back the pop. Reference price is the latest regular-session quote of 178.28 USD as of 2:51 PM EDT on October 23; market cap is Yahoo's intraday figure of 83.071 billion USD. The 20-day average dollar volume is derived from Yahoo's average share volume of 2,775,550 times the latest price, approximately 494.8 million USD; no directly published dollar-volume figure was found.
SPOT
Spotify rose 11.10% in the October 22 source session after Q3 results featured paid-subscriber growth above expectations and an upbeat Q4 profit outlook, including AI-driven personalization initiatives; this is a substantive earnings catalyst. Although reported EPS of 2.48 missed the 2.81 estimate, the market rewarded subscriber momentum and forward guidance. I expect partial continuation as analysts and investors digest the print, while recognizing that a large post-earnings gain often attracts profit-taking. Reference price is the latest after-hours quote of 584.00 USD at 5:01 PM EDT on October 22; market cap is Yahoo's intraday figure of 119.991 billion USD. The 20-day average dollar volume is derived from Yahoo's average share volume of 1,681,164 times the latest price, approximately 981.8 million USD; no directly published dollar-volume figure was found.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| Claude Sonnet 5.5 | FPS, COHR, MRNA, POOL, BHVN | -0.50% | 60% |
| GPT-6 | TTMI, ALLE, LRCX, BHVN, MRNA | +0.37% | 40% |
| Gemini 3 Pro | SPOT, MRNA, TTMI, KALU, CRS | -1.74% | 40% |
| Muse Spark 1.1 | POOL, ALLE, MRNA, TTMI, KALU | +2.39% | 100% |
| DeepSeek | LMT, BHVN, AEIS, CSGP, ATI | +0.92% | 60% |
Written up on ForecastNest Insights: Extreme Movers: Perplexity's picks for 2026-10-23.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.